Zhehang Chen

406 total citations · 1 hit paper
7 papers, 307 citations indexed

About

Zhehang Chen is a scholar working on Molecular Biology, Oncology and Immunology. According to data from OpenAlex, Zhehang Chen has authored 7 papers receiving a total of 307 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Molecular Biology, 3 papers in Oncology and 2 papers in Immunology. Recurrent topics in Zhehang Chen's work include Immune cells in cancer (2 papers), Cell death mechanisms and regulation (1 paper) and Fibroblast Growth Factor Research (1 paper). Zhehang Chen is often cited by papers focused on Immune cells in cancer (2 papers), Cell death mechanisms and regulation (1 paper) and Fibroblast Growth Factor Research (1 paper). Zhehang Chen collaborates with scholars based in China and United States. Zhehang Chen's co-authors include Weiyi Shen, Yadong Qi, Shujie Chen, Chaochao Xu, Tongyao Hou, Lan Wang, Ying Zhang, Yifeng Lin, Lina Fan and Yanqin Long and has published in prestigious journals such as Journal of Experimental & Clinical Cancer Research, Gut Microbes and Journal of Gastroenterology.

In The Last Decade

Zhehang Chen

6 papers receiving 307 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Fusobacterium nucleatum promotes colorectal cancer metastasis through miR-1322/CCL20 axis and M2 polarization

2021 207 citations Chaochao Xu, Lina Fan et al. Gut Microbes profile →

Peers

Zhehang Chen

MB

ONCOL

IMMUN

CR

PHARM

Sujit Suklabaidya India

Sonu Kumar Gupta India

Aswathy R. Devan India

Pan Cheng-en China

Alia Aldahlawi Saudi Arabia

Lin Gan China

Thi Thinh Nguyen South Korea

Mina Yazdi Iran

TaChung Yu China

Sujit Suklabaidya India

Zhehang Chen

148 ×0.8

MB

105 ×1.1

ONCOL

71 ×1.3

IMMUN

42 ×1.1

CR

35 ×1.0

PHARM

Citations per year, relative to Zhehang Chen Zhehang Chen (= 1×) peers Sujit Suklabaidya

Countries citing papers authored by Zhehang Chen

Since Specialization

Citations

This map shows the geographic impact of Zhehang Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zhehang Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zhehang Chen more than expected).

Fields of papers citing papers by Zhehang Chen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zhehang Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zhehang Chen. The network helps show where Zhehang Chen may publish in the future.

Co-authorship network of co-authors of Zhehang Chen

This figure shows the co-authorship network connecting the top 25 collaborators of Zhehang Chen. A scholar is included among the top collaborators of Zhehang Chen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zhehang Chen. Zhehang Chen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

7 of 7 papers shown

1.

Wang, Qianqian, Ke Guo, Yunkun Lu, et al.. (2025). CD47 blockade reverses resistance to HDAC inhibitor by liberating anti-tumor capacity of macrophages. Journal of Experimental & Clinical Cancer Research. 44(1). 67–67. 9 indexed citations

2.

Xiao, Peng, Zhehang Chen, Wenhao Xia, et al.. (2025). Targeting hyaluronan synthesis enhances the therapeutic effectiveness of biologics in inflammatory bowel disease. JCI Insight. 10(1).

3.

Zhang, Ying, Weiyi Shen, Zhehang Chen, et al.. (2024). Resistant starch reduces glycolysis by HK2 and suppresses high-fructose corn syrup-induced colon tumorigenesis. Journal of Gastroenterology. 59(10). 905–920. 5 indexed citations

4.

Chen, Zhehang, Yadong Qi, Jiamin He, et al.. (2022). Distribution and characterization of extrachromosomal circular DNA in colorectal cancer. Molecular Biomedicine. 3(1). 38–38. 6 indexed citations

5.

Xu, Chaochao, Lina Fan, Yifeng Lin, et al.. (2021). Fusobacterium nucleatum promotes colorectal cancer metastasis through miR-1322/CCL20 axis and M2 polarization. Gut Microbes. 13(1). 1980347–1980347. 207 indexed citations breakdown →

6.

Wang, Saisai, et al.. (2017). 18 β-glycyrrhetinic acid exhibits potent antitumor effects against colorectal cancer via inhibition of cell proliferation and migration. International Journal of Oncology. 51(2). 615–624. 41 indexed citations

7.

Chen, Dong, Fang Dai, Zhehang Chen, et al.. (2016). Dimethoxy Curcumin Induces Apoptosis by Suppressing Survivin and Inhibits Invasion by Enhancing E-Cadherin in Colon Cancer Cells. Medical Science Monitor. 22. 3215–3222. 39 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact